SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Street J, Winter D, Wang JH, Wakai A, McGuinness A, Redmond HP 2000 Is human fracture hematoma inherently angiogenic? Clin Orthop 378: 224237.
  • 2
    Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N 1999 VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623628.
  • 3
    Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH 2002 Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 96569661.
  • 4
    Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T 2003 Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32: 491501.
  • 5
    Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW 2000 Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141: 16671674.
  • 6
    Glowacki J 1998 Angiogenesis in fracture repair. Clin Orthop 355 (Suppl): 8289.
  • 7
    Nikol S, Huehns TY 2001 Preclinical and clinical experience in vascular gene therapy: Advantages over conservative/standard therapy. J Invasive Cardiol 13: 333338.
  • 8
    Nikol S, Engelmann MG, Pelisek J, Fuchs A, Golda A, Shimizu M, Mekkaoui C, Rolland PH 2002 Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs. Acta Physiol Scand 176: 151159.
  • 9
    Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J 2002 Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110: 751759.
  • 10
    Ferrara N 1999 Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527543.
  • 11
    Shea L, Smiley E, Bonadio J, Mooney D 1999 DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17: 551554.
  • 12
    Bonadio J, Smiley E, Patil P, Goldstein S 1999 Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 5: 753759.
  • 13
    Fang J, Zhu Y-Y, Smiley E, Bonadio J, Rouleau JA, Goldstein SA, McCauley LK, Davidson B, Roessler B 1996 Stimulation of new bone formation by direct transfer of osteoinductive plasmid genes. Proc Natl Acad Sci USA 93: 57535758.
  • 14
    Tuli S, Gupta K 1981 Bridging of large chronic osteoperiosteal gaps by allogeneic decalcified bone matrix implants in rabbits. J Trauma 21: 894898.
  • 15
    Wittbjer J, Palmer B, Thorngren KG 1982 Osteogenetic prop-erties of reimplanted decalcified and undecalcified autologous bone in the rabbit radius. Scand J Plast Reconstr Surg 16: 239244.
  • 16
    Mackenzie DJ, Sipe R, Buck D, Burgess W, Hollinger J 2001 Recombinant human acidic fibroblast growth factor and fibrin carrier regenerates bone. Plast Reconstr Surg 107: 989996.
  • 17
    Yasko A, Lane J, Fellinger E, Rosen V, Wozney J, Wang E 1992 The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg Am 74: 659670.
  • 18
    Probst A, Spiegel HU 1997 Cellular mechanisms of bone repair. J Invest Surg 10: 7786.
  • 19
    Bostrom MP, Camacho NP 1998 Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop 355: 244282.
  • 20
    Boden SD, Kang J, Sandhu H, Heller JG 2002 Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial. 2002 Volvo Award in clinical studies. Spine 27: 26622673.
  • 21
    Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S 2001 Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83 (Suppl): 151158.
  • 22
    Kujala S, Raatikainen T, Ryhanen J, Kaarela O, Jalovaara P 2002 Composite implant of native bovine bone morphogenetic protein (BMP) and biocoral in the treatment of scaphoid nonunions-a preliminary study. Scand J Surg 91: 186190.
  • 23
    Hiltunen MO, Ruuskanen M, Huuskonen J, Mahonen AJ, Ahonen M, Rutanen J, Kosma VM, Mahonen A, Kroger H, Yla-Herttuala S 2003 Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J 17: 11471149.
  • 24
    Tarkka T, Sipola A, Jämsä T, Soini Y, Ylä-Herttuala S, Tuukkanen J, Hautala T 2003 Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5: 560566.
  • 25
    Eckardt H, Bundgaard KG, Christensen KS, Lind M, Hansen ES, Hvid I 2003 Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res 21: 335340.
  • 26
    Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM 1996 Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94: 32813290.
  • 27
    Reed AA, Joyner CJ, Brownlow HC, Simpson AH 2002 Human atrophic fracture non-unions are not avascular. J Orthop Res 20: 593599.
  • 28
    Capito RM, Spector M 2003 Scaffold-based articular cartilage repair. IEEE Eng Med Biol Mag 22: 4250.